WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ: CLZR) reports findings of six recently published, peer-reviewed studies in which Candela’s Vbeam® Perfecta and GentleLASE® were highlighted. The studies for the Vbeam Perfecta tested the effectiveness and safety for treatment of various lesions. The GentleLASE studies tested the efficacy of treating pigmented lesions and showcased a head-to-head comparison with the IPL system specific to hair removal treatment.
